- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02343055
COPE With COPD Trial
Collaborative Self-Management Patient Education Will Improve Health Outcomes in COPD
The overall objective of this study is to evaluate a collaborative self-management intervention in patients with moderate to severe COPD in a primary care population. To achieve this objective the investigators developed a diagnostic and treatment pathway for the management of COPD in primary care that is based on national guidelines and focused on patient self-management.
.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Ontario
-
Amherstburg, Ontario, Canada, N9V 0B4
- Amherstburg FHT
-
Chatham, Ontario, Canada, N7L 5K5
- Chatham-Kent FHT
-
Harrow, Ontario, Canada, NOR 1G0
- Harrow FHT
-
Leamington, Ontario, Canada, N8H 1N8
- Leamington FHT
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Current or Ex-smokers
- 40 years of age or over
- Minimum 10 pack year smoking history
- Post-bronchodilator FEV1 of 70% or less (4 puffs of Salbutamol) and Forced Expiratory Volume at 1sec to Forced Vital Capacity (FEV1/FVC) ratio 70% or less
- A history of two exacerbations (involving treatment and/or visit to a health care practitioner) in the past 3 years OR 1 exacerbation in the past year
- Provides informed consent
Exclusion Criteria:
- COPD exacerbation in the past 4 weeks
- Diagnosis of asthma prior to the age of 40 years
- Co-existing illness that could interfere with study results (ie. Congestive Heart Failure with exacerbation of symptoms)
- Scheduled for COPD rehabilitation
- A terminal illness
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: Case Management and Self-Management Education
A Certified Respiratory Educator (CRE) will obtain a detailed COPD history, provide general and self-management education, and confirm a management plan with the primary care physician.
Specific elements of evidence-based management are targetted for intervention.
Subjects will return for a follow-up visit in-person with the interdisciplinary care team including a CRE to review their health status including COPD symptoms, exacerbation diary, symptoms, MRC scale, etc as a minimum at 3 and 12 months.
Telephone follow up will occur at a minimum at 6 and 9 months.
|
A Certified Respiratory Educator (CRE) will obtain a detailed COPD history, provide general and self-management education, and confirm a management plan with the primary care physician.
Specific elements of evidence-based management are targetted for intervention.
Subjects will return for a follow-up visit in-person with the interdisciplinary care team including a CRE to review their health status including COPD symptoms, exacerbation diary, symptoms, MRC scale, etc as a minimum at 3 and 12 months.
Telephone follow up will occur at a minimum at 6 and 9 months.
|
Comparatore placebo: Usual Care
A Certified Respiratory Educator (CRE) will meet with subjects to obtain a detailed COPD history and do a breathing test.
Subjects will receive COPD care as usually provided by their physician.
|
A Certified Respiratory Educator (CRE) will obtain a detailed COPD history, provide general and self-management education, and confirm a management plan with the primary care physician.
Specific elements of evidence-based management are targetted for intervention.
Subjects will return for a follow-up visit in-person with the interdisciplinary care team including a CRE to review their health status including COPD symptoms, exacerbation diary, symptoms, MRC scale, etc as a minimum at 3 and 12 months.
Telephone follow up will occur at a minimum at 6 and 9 months.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
COPD Assessment Test (CAT)
Lasso di tempo: 1 Year
|
COPD related quality of life measure in primary care.
|
1 Year
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Health Care Utilization for Emergency Department visits proportion and rate per year
Lasso di tempo: 1 year
|
The proportion of subjects that utilized the Emergency for a COPD exacerbation
|
1 year
|
Health Care Utilization for Hospital Admission proportion and rate per year
Lasso di tempo: 1 year
|
The proportion of subjects that were admitted to hospital for a COPD exacerbation An exacerbation is defined as an increase in or the onset of more than one respiratory symptom (cough, sputum, sputum purulence, wheezing, or dyspnea) lasting 3 days or more and requiring treatment with an antibiotic or a systemic corticosteroid.
Respiratory status had to return to baseline for at least 72 hours before another exacerbation would be counted.
|
1 year
|
Severe Exacerbation proportion and rate per year
Lasso di tempo: 1 year
|
The proportion of subjects experiencing one or more exacerbations in the study interval.
An exacerbation diary will be completed for each event.
|
1 year
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Quality of Life
Lasso di tempo: 1 year
|
Improvement of Quality of Life using the CAT score(COPD Assessment Test)
|
1 year
|
Improvement in Knowledge of COPD and confidence in self-management
Lasso di tempo: 1 year
|
Improvement in Bristol COPD Knowledge Questionnaire and patient self report
|
1 year
|
Process of Care
Lasso di tempo: 1 year
|
Process of care: have written action plan, used action plan, advised to quit smoking, offered pharmacologic help with quitting, quit smoking, current packs/day, diagnosis confirmed by spirometry, vaccination rates, instructed on inhaler technique, vaccination rates
|
1 year
|
Dyspnea Improvement
Lasso di tempo: 1 year
|
Change in dyspnea using the modified MRC questionnaire - Medical Research Council (MRC).
|
1 year
|
Disease control
Lasso di tempo: 1 year
|
Disease control using the Clinical COPD questionnaire (CCQ)
|
1 year
|
Symptom Profile
Lasso di tempo: 1 year
|
Change in Symptom profile (cough, wheeze, sputum production)
|
1 year
|
Forced Expiratory Volume at 1sec (FEV1) % predicted
Lasso di tempo: 1 year
|
FEV1
|
1 year
|
Proportion of Patients on therapy appropriate to their stage of disease
Lasso di tempo: 1 year
|
Evaluate medication prescribed related to stage of disease
|
1 year
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Christopher Licskai, Lawson Health Research Institution
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 00000941
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Case Management and Self-Management Education
-
Nationwide Children's HospitalNational Institute on Drug Abuse (NIDA)CompletatoDepressione | Comportamento a rischio | Ideazione suicida | Uso di sostanzeStati Uniti
-
University of Lausanne HospitalsSconosciutoUtenti frequenti del pronto soccorso (FUED)Svizzera
-
Université de SherbrookeQuebec Pain Research NetworkCompletatoDolore lombare meccanicoCanada
-
Baylor College of MedicineCompletatoDisturbi d'ansia | Disturbi da Uso di SostanzeStati Uniti
-
Dr. Faizan AwanCompletatoCovid19 | Stress occupazionaleRegno Unito
-
Cheikh Anta Diop University, SenegalLondon School of Hygiene and Tropical MedicineCompletato
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)ReclutamentoDisturbo da uso di oppioidiStati Uniti
-
Royal Victoria Hospital, CanadaNon ancora reclutamentoDisturbi da Uso di Sostanze | Angoscia, Emotivo | Problema di salute mentaleCanada
-
Universitätsklinikum Hamburg-EppendorfFederal Ministry of Health, Germany; State of Northrhine-Westfalia; State of Hessen e altri collaboratoriCompletatoDipendenza da oppioidiGermania
-
Mayo ClinicCompletatoQualità della vita | Chirurgia gastrointestinale complessaStati Uniti